SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

ALNY is drawing attention after a sharp post-earnings selloff and fresh lows, as traders focus on slower Amvuttra demand growth and reimbursement concerns despite strong product sales. The community is split between fears that commercial momentum is weakening and dip-buying optimism centered on the RNAi pipeline and upcoming clinical and regulatory catalysts.

Toast, Inc. engages in the development and provision of consumer payment application for restaurants. It offers terminals, kiosk, guest facing display, and system accessories. The firm also offers point of sale, reporting and analytics, online ordering and delivery, and kitchen display system. The company was founded by Jonathan Grimm, Aman Narang, and Stephen J. Fredette in December 2011 and is headquartered in Boston, MA.

Toast Inc - Ordinary Shares - Class A

Toast Inc

Toasts quarterly results are driving discussion: traders cite revenue growth and higher full-year profit guidance, while debating an EPS shortfall against some estimates and the stocks muted or negative reaction. Some remain bullish on the companys growth, while others question why strong results have not translated into share-price gains; the CFO transition is also drawing notice.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

SNOW is drawing attention after rebounding from a recent washout, with some traders viewing the move as a buying opportunity. The broader debate remains cautious: many question whether customers will cut usage and AI workloads under budget pressure, which could weigh on Snowflakes consumption-based revenue.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

GlobalFoundries quarterly results and outlook are driving discussion: traders note the earnings and guidance beat, but debate why the shares have remained volatile amid analyst target cuts. Bulls see the pullback as an opportunity, while skeptics question demand for mature-node capacity and whether customer orders will hold up.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Traders are debating ABVXs prolonged slide despite positive Phase 3 maintenance data for obefazimod in ulcerative colitis and a planned FDA filing. Bulls speculate about a Big Pharma buyout and the drugs potential, while skeptics see no confirmed deal and point to the wait for Crohns data and broader biotech weakness.

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Natera Inc

Nateras quarterly results and abrupt CEO departure are driving a sharp selloff: traders cite a wider loss despite revenue growth and raised guidance, while debating whether the drop overreacts to the leadership change or reflects concern about losses and valuation. Options activity is also drawing attention, with traders positioning on both sides.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,372,680,256.2826 in circulation. The last known price of Stellar is 0.15097866 USD and is down -1.62 over the last 24 hours. It is currently trading on 848 active market(s) with $82,748,701.06 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLMs prolonged selloff and failure to hold recent gains dominate the discussion, with bearish traders pointing to persistent selling and broader crypto weakness while others see the dip as a buying opportunity. The debate also centers on Stellars institutional tokenization and DTCC-related prospects: bulls expect adoption to matter over time, while skeptics argue it has not translated into stronger token performance and question XLMs tokenomics.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

The FDA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer is driving attention, with traders debating whether the application can succeed despite concerns that the overall-survival data did not meet statistical significance. Bulls cite progression-free-survival results, broader positive data and AstraZenecas backing, while bears emphasize the FDAs stated OS requirement, making the decision a high-stakes binary catalyst.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Anticipation of Senseonics upcoming Q3 results is the main focus, with traders debating whether continued commercial growth will sustain the recent strength or whether the stock will fade after earnings. Bulls point to recent business momentum, while skeptics cite cash burn, dilution risk, and a history of post-earnings pullbacks.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluences repeated fiscal-year guidance cuts, driven by Houston manufacturing delays that are disrupting production and delivery, dominate discussion and have intensified concerns about execution, margins, and management credibility. Some traders see the beaten-down shares and leadership changes as a turnaround or short-squeeze setup, while skeptics argue the company must demonstrate operational improvement before sentiment can recover.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Share

Sam